Yi P

References (4)

Title : Esterase-activatable dimeric HDAC inhibitor nanotherapeutics for enhanced lymphoma epigenetic therapy - Li_2026_Colloids.Surf.B.Biointerfaces_261_115416
Author(s) : Li T , Zhuang W , Fan S , Yi P , Ouyang G , Qian W
Ref : Colloids Surf B Biointerfaces , 261 :115416 , 2026
Abstract :
PubMedSearch : Li_2026_Colloids.Surf.B.Biointerfaces_261_115416
PubMedID: 41538977

Title : Phenolic and bisamide derivatives from Aglaia odorata and their biological activities - Yang_2022_Nat.Prod.Res__1
Author(s) : Yang X , Yu Y , Wu P , Liu J , Li Y , Tao L , Tan R , Hao X , Yuan C , Yi P
Ref : Nat Prod Res , :1 , 2022
Abstract :
PubMedSearch : Yang_2022_Nat.Prod.Res__1
PubMedID: 36580570

Title : Polycyclic polyprenylated acylphloroglucinols with acetylcholinesterase inhibitory activities from Hypericum perforatum - Lou_2020_Fitoterapia__104550
Author(s) : Lou H , Yi P , Hu Z , Li Y , Zeng Y , Gu W , Huang L , Yuan C , Hao X
Ref : Fitoterapia , :104550 , 2020
Abstract :
PubMedSearch : Lou_2020_Fitoterapia__104550
PubMedID: 32173424

Title : Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives - Yan_2009_Bioorg.Med.Chem_17_6937
Author(s) : Yan J , Sun L , Wu G , Yi P , Yang F , Zhou L , Zhang X , Li Z , Yang X , Luo H , Qiu M
Ref : Bioorganic & Medicinal Chemistry , 17 :6937 , 2009
Abstract :
PubMedSearch : Yan_2009_Bioorg.Med.Chem_17_6937
PubMedID: 19726199